A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis

被引：28

作者：

Butts, Charles

Maksymiuk, Andrew

Goss, Glenwood

Soulieres, Denis

Marshall, Ernie

Cormier, Yvon

Ellis, Peter M.

Price, Allan

Sawhney, Ravinder

Murray, Nevin

机构：

[1] Cross Canc Inst, Edmonton, AB, Canada

[2] CancCare Manitoba, Winnipeg, MB, Canada

[3] Univ Ottawa, Ottawa Hosp Reg Canc Ctr, Ottawa, ON K1N 6N5, Canada

[4] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada

[5] Clatterbridge Ctr Oncol, Bebington, England

[6] Univ Laval, Quebec City, PQ G1K 7P4, Canada

[7] Western Gen Hosp, Edinburgh, Midlothian, Scotland

[8] Juravinski Canc Ctr, Hamilton, ON, Canada

[9] Fraser Valley Canc Ctr, Surrey, BC, Canada

[10] BC Canc Agcy, Vancouver, BC, Canada

来源：

关键词：

D O I：

10.1097/01.JTO.0000283139.22682.5e

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S332 / S333

页数：2